
    
      Study Design One dialysis unit shift comprising up to 200 patients. Study participation will
      last for 12 months broken into 3 phases as described below.

      Phase 1 (1-3 months): Develop individualized patient models and Anemia Management Protocols
      (AMP) while patients are receiving standard medical care.

      Phase 2 (9 months): Individualized AMP study period. Phase 3 (9 months): Follow up period:
      return to standard-care AMP.

      The individual AMP will be utilized weekly during the 9 months of Phase 2.

      The 3 objectives will be evaluated and updated weekly, Baseline to Year 1.

      All Epo dosing recommendations must be reviewed by the treating physician who can either
      accept or modify doses at his/her discretion based on clinical event that are not includes in
      the transmitted data such as bleeding, infection, and hospitalization.
    
  